Literature DB >> 1436124

Evidence for M1 muscarinic cholinoceptors mediating facilitation of noradrenaline release in guinea-pig carotid artery.

M A Casado1, J Marín, M Salaices.   

Abstract

The muscarinic agonists acetylcholine (1-50 mumol/l), carbachol (1-10 mumol/l) and McN-A-343 (1-50 mumol/l, selective for M1 receptors) increased, in a concentration-dependent manner, the electrically-evoked tritium overflow from guinea-pig carotid arteries preincubated with [3H]-noradrenaline. The increase caused by acetylcholine was not modified by hexamethonium (300 mumol/l) but was reduced by the muscarinic receptor antagonists methylatropinium (0.5 and 1 nmol/l, non-selective), pirenzepine (1 and 5 nmol/l, M1-selective), methoctramine (1 and 5 mumol/l, M2-selective) and p-fluoro-hexahydro-sila-difenidol (0.1-1 mumol/l, M3-selective). The order of potencies (expressed as negative logarithms of concentrations that reduced by 50% the facilitatory effect of acetylcholine) was: methyl-atropinium (9.93) > pirenzepine (8.83) > p-fluoro-hexahydro-siladifenidol (6.81) > or = methoctramine (6.20). These results demonstrate the existence of facilitatory M1 receptors modulating noradrenaline release in blood vessels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436124     DOI: 10.1007/bf00171079

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

Review 1.  Heterogeneity of vascular muscarinic receptors.

Authors:  R M Eglen; R L Whiting
Journal:  J Auton Pharmacol       Date:  1990-08

2.  Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.

Authors:  M J Alonso; S Arribas; J Marín; G Balfagón; M Salaices
Journal:  Brain Res       Date:  1991-12-13       Impact factor: 3.252

Review 3.  Polymethylene tetramines: a new generation of selective muscarinic antagonists.

Authors:  C Melchiorre
Journal:  Trends Pharmacol Sci       Date:  1988-06       Impact factor: 14.819

Review 4.  Muscarinic receptor differentiation.

Authors:  F Mitchelson
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

5.  M3-muscarinic receptor mediates prejunctional inhibition of noradrenaline release and the relaxation in cat femoral artery.

Authors:  F A Fernándes; M J Alonso; J Marín; M Salaices
Journal:  J Pharm Pharmacol       Date:  1991-09       Impact factor: 3.765

Review 6.  Presynaptic receptors.

Authors:  K Starke
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

7.  A presynaptic excitatory M1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine.

Authors:  A Habermeier-Muth; U Altes; K M Forsyth; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

8.  Presynaptic muscarinic receptor subtypes involved in the inhibition of acetylcholine and noradrenaline release in bovine cerebral arteries.

Authors:  M Ferrer; R Galván; J Marín; G Balfagón
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

9.  Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria.

Authors:  M Cost; H Majewski
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

  9 in total
  3 in total

1.  M1 muscarinic receptor-induced facilitation of ACh and noradrenaline release in the rat bladder is mediated by protein kinase C.

Authors:  G T Somogyi; M Tanowitz; G Zernova; W C de Groat
Journal:  J Physiol       Date:  1996-10-01       Impact factor: 5.182

2.  Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.

Authors:  R L McDonald; P F Vaughan; C Peers
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

3.  Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice.

Authors:  Anne-Ulrike Trendelenburg; Jesus Gomeza; Werner Klebroff; Hongxia Zhou; Jürgen Wess
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.